Microbiome Space in Spotlight as Microbiotica Sets Funding Record

Competition is heating up in the microbiome niche as UK-based Microbiotica raised €60M (£50M) in a Series B round to advance two candidates designed to treat cancer and ulcerative colitis.

Microbiotica’s financing sets a record in Europe for microbiome specialist biotechs. The round…

Source: www.labiotech.eu – Read more